Efficacy and Tolerance Evaluation of a "Revitalizing" Face Treatment

Derming

Status

Completed

Conditions

Face Aging/Photo Aging of Moderate Grade

Treatments

Other: Nutriage SPF 30 day cream and Nutriage night cream (Difa Cooper S.p.a, Italy)

Study type

Interventional

Funder types

Other

Identifiers

NCT03276897

E0517

Details and patient eligibility

About

Efficacy and Tolerance Evaluation of a"revitalizing" face treatment consisting of a day and a night cream

Full description

Aim of the study was to evaluate clinically and by non-invasive instrumental evaluations the activity of a "revitalizing" face treatment consisting of a day and a night cream, applied for an uninterrupted period of 3 months, by female volunteers, aged 35-60 years, with aging/photo aging of moderate grade.

Enrollment

22 patients

Sex

Female

Ages

35 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

female sex,
age 35-60 years,
Caucasian subjects,
presence of moderate face ritidosis,
agreeing to present at each study visit without make-up,
accepting to follow the instructions received by the investigator,
accepting to not change their habits regarding food, physical activity, face cleansing and make- up use,
agreeing not to apply or take any product or use face massages or other means known to improve skin wrinkle and skin qualities during the entire duration of the study,
accepting not to expose their face to strong UV irradiation (UV session, or sun bathes), during the entire duration of the study,
no participation in a similar study currently or during the previous 3 months
accepting to sign the Informed consent form.

Exclusion criteria

Pregnancy,
lactation,
sensitivity to the test products or their ingredients (to be assessed by the investigator during the baseline visit),
subjects whose insufficient adhesion to the study protocol is foreseeable.
presence of cutaneous disease on the tested area as lesions, scars, malformations,
recurrent facial/labial herpes,
clinical and significant skin condition on the test area (e.g. active eczema, dermatitis, psoriasis etc.).
endocrine disease,
hepatic disorder,
renal disorder,
cardiac disorder,
pulmonary disease,
cancer,
neurological or psychological disease,
inflammatory/immunosuppressive disease,
drug allergy.
anti-inflammatory drugs, anti-histaminic, topic (application on the face) and systemic corticosteroids, narcotic, antidepressant, immunosuppressive drugs (with the except of hormonal treatment starting more than 1 year ago),
using of drugs or dietary supplements able to influence the test results in the investigator opinion.